PUBLISHER: Grand View Research | PRODUCT CODE: 1869684
PUBLISHER: Grand View Research | PRODUCT CODE: 1869684
The global flea, tick and heartworm products market size was estimated at USD 7.85 billion in 2024 and is projected to reach USD 15.21 billion by 2033, growing at a CAGR of 7.62% from 2025 to 2033. The market is experiencing growth driven by the increasing prevalence of vector-borne diseases, the growing importance of preventive care, and the emergence of novel FTH products.
A rise in the spread of heartworm disease and cases of parasitic infestations among animals is also expected to fuel the growth of the flea, tick and heartworm products industry. The expansion of flea-, tick-, and mosquito-borne diseases like Lyme disease, ehrlichiosis, and heartworm is creating greater awareness among pet owners and veterinarians about preventive care. In recent years, their spread has been on the rise globally. According to 2023 data published by the American Veterinary Medical Association (AVMA) and the American Heartworm Society (AHS), estimated that in 2022, many veterinary clinics in the U.S. handled over 100+ cases of heartworm disease in animals per clinic. Of the total veterinarians who responded to this survey, 29% reported that heartworm disease cases have steadily risen over the last year. The prevalence of heartworm diseases was reported to be about 20% for dogs and 33% for cats in the U.S., according to a March 2024 study published in the Parasites & Vectors journal.
In addition, a March 2024 release by the British Small Animal Veterinary Association (BSAVA) reported that even though the disease is not endemic in the UK, heartworm disease diagnosis has been steadily increasing, with most cases found in dogs. Additionally, a study was conducted in Australia to understand the prevalence of heartworm infection in dogs. This February 2023 study inferred that the prevalence was estimated to be as high as 32.1%, varying slightly in different areas of the country.
The market is set to experience high growth prospects in the forecast period. One of the crucial drivers in this market is the increasing emphasis put by veterinary professionals on the importance of preventive care in animals for managing parasitic infections like flea, tick, and heartworm. Preventive care focuses on administering FTH medication to animals like cats & dogs since their early years of development, irrespective of infestation. Product manufacturers are also actively innovating and seeking regulatory approvals to increase their product portfolio and assist in effectively managing these conditions.
Furthermore, a Merck Animal Health survey of August 2025 revealed a significant gap between pet owners' intentions and their actual compliance with flea and tick prevention. Most owners recognize the importance of treatment, struggle with timely administration, seasonal misconceptions, and lack of awareness about vector-borne diseases like ehrlichiosis. This highlights an urgent need for education and long-duration solutions. These compliance challenges are driving demand for innovative, long-lasting, and veterinarian-prescribed flea and tick preventives. As awareness grows, companies offering annual or extended-duration treatments are likely to see strong adoption and revenue growth.
Global Flea, Tick and Heartworm Products Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global flea, tick and heartworm products market report based on product, type, animal, mode of delivery, parasite, care, distribution channel, and region: